| Vial description: |
HLA-DNA, HLA-DZA, MHC DN-alpha, MHC DZ alpha, MHC class II antigen DOA |
| Category: |
antigen |
| Raised in: |
laboratory |
| Clone: |
1 vial |
| Form: |
Purified |
| Reactivity: |
not determined |
| Purity: |
>, 90% |
| Molecular weight: |
1 kDa, 24 |
| Source: |
coli, E |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
P06340 |
| Application: |
not determined |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Conjugation: |
histidine |
| Gene target: |
His-tag), HLA class II DO alpha / HLA-DOA (26-217 |
| Short name: |
His-tag) Antibody, anti-HLA class II DO alpha / HLA-DOA (26-217 |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Label: |
His |
| Alternative name: |
DO a (26-217, class II, histidine-detection labelled) (Antibody to), antibody to-Human leukocyte antigen class II DO a / major histocompatibility aggregate |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
DO alpha, H2-Oa and IDBG-170180 and ENSMUSG00000024334 and 15001, HLA-DNA and HLA-DZA and HLADZ, HLA-DOA and IDBG-628885 and ENSBTAG00000006490 and 525727, HLA-DOA and IDBG-81729 and ENSG00000204252 and 3111, MHC class II receptor activity, Plasma membranes, class II, this GO :0002587 and negative regulation of antigen processing and presentation of peptide antigen via MHC class II and biological process this GO :0005515 and protein binding and molecular function this GO :0005765 and lysosomal membrane and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006955 and immune response and biological process this GO :0007165 and signal transduction and biological process this GO :0010008 and endosome membrane and cellular component this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0019882 and antigen processing and presentation and biological process this GO :0019886 and antigen processing and presentation of exogenous peptide antigen via MHC class II and biological process this GO :0023026 and MHC class II protein complex binding and molecular function this GO :0032395 and MHC class II receptor activity and molecular function this GO :0042613 and MHC class II protein complex and cellular component this GO :0045580 and regulation of T cell differentiation and biological process, this GO :0005515 : protein binding, this GO :0005515 : protein binding and also this GO :0023026 : MHC class II protein complex binding and also this GO :0032395 : MHC class II receptor activity, this GO :0023026 : MHC class II protein complex binding, this GO :0032395 : MHC class II receptor activity, major histocompatibility complex |
| Identity: |
4936 |
| Gene: |
HLA-DOA |
More about : HLA-DOA |
| Long gene name: |
DO alpha , class II, major histocompatibility complex |
| Synonyms gene: |
HLA-DZA HLA-DNA |
| Synonyms: |
HLA-D0-alpha |
| Locus: |
6p21, 32 |
| Discovery year: |
2001-06-22 |
| GenBank acession: |
M31525 |
| Entrez gene record: |
3111 |
| Pubmed identfication: |
2370084 |
| RefSeq identity: |
NM_002119 |
| Classification: |
C1-set domain containing Histocompatibility complex |
| Havana BLAST/BLAT: |
OTTHUMG00000031211 |
| Locus Specific Databases: |
IMGT/HLA Database |